ahlam1399
07-28-2015, 05:32 AM
Glenmark Pharmaceuticals? Finacea generic infringes Bayer patent ? court
NEW YORK, July 27 (Reuters) - India's Glenmark Pharmaceuticals' proposed generic version of Bayer AG's Finacea, a gel for treating the common skin condition rosacea, infringes Bayer's patent, a U.S. court ruled on Monday.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/487c2a60/sc/7/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=5n_rADSNnPA:JTCedt9E3PM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=5n_rADSNnPA:JTCedt9E3PM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=5n_rADSNnPA:JTCedt9E3PM:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=5n_rADSNnPA:JTCedt9E3PM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=5n_rADSNnPA:JTCedt9E3PM:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/5n_rADSNnPA
NEW YORK, July 27 (Reuters) - India's Glenmark Pharmaceuticals' proposed generic version of Bayer AG's Finacea, a gel for treating the common skin condition rosacea, infringes Bayer's patent, a U.S. court ruled on Monday.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/487c2a60/sc/7/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=5n_rADSNnPA:JTCedt9E3PM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=5n_rADSNnPA:JTCedt9E3PM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=5n_rADSNnPA:JTCedt9E3PM:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=5n_rADSNnPA:JTCedt9E3PM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=5n_rADSNnPA:JTCedt9E3PM:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/5n_rADSNnPA